Clinical Trials Browser

Phase 2 × Glioblastoma × ACT001 × Clear all

NCT06894225 2025-04-06

Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature

Phase 2 Not yet recruiting

Glioblastoma